Introducing bio-printing technology for 3D heart models designed for personalized medicine and transplantation.
In Dr. Carmine Gentile's laboratory in Sydney, research is being conducted to develop bio-printed heart tissue using patient-specific cells to minimize the risk of transplant rejection. In a 2020 study, mouse cells were bio-printed using alginate-gelatin hydrogel with CELLINK's "BIO X." The bio-printed heart cells were cultured for 7 to 14 days until they developed into pulsating patches of heart tissue. During open-heart surgery on mice from which the cells were derived, the vascularized heart patches were transplanted into the damaged areas of the heart. The transplantation aimed to test the safety of the bio-printed patches and confirm their positive effects on heart function, both of which were validated. [Summary] - Facility: Dr. Carmine Gentile's laboratory in Sydney - Challenge: Development of bio-printed heart tissue - Results: - Safety of the bio-printed patches - Positive effects on heart function *For more details, please refer to the related links or feel free to contact us.*
Inquire About This Product
basic information
For more details, please refer to the related links or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the related links or feel free to contact us.
catalog（2）
Download All Catalogs
News about this product（2）
Company information
Our company has spent eight years on the technological innovation of biomaterials and commercialized bioink in 2016. We have grown into a leading company in bioprinting technology, providing systems to optimize cell-based applications for over 1,000 scientists in more than 55 countries worldwide. Please feel free to contact us if you have any inquiries.
![[Use Case] Bioprinting of First-Generation Human Mesenchymal Stem Cells and Vascular Endothelial Cells](https://image.mono.ipros.com/public/product/image/76a/2000657670/IPROS03351688618333609572.png?w=280&h=280)
